Sporozoite Asparagine-rich Protein 1 (SAP1)

Sporozoite Asparagine-rich Protein 1 (SAP1) is an essential protein in the life cycle of the malaria parasite Plasmodium falciparum, specifically required for the transition from the mosquito vector to the mammalian host. It functions as a critical post-transcriptional regulator that controls the abundance and stability of transcripts essential for liver-stage infectivity, such as the Upregulated in Infectious Sporozoites (UIS) genes. Research indicates that the targeted deletion of the SAP1 gene results in parasites that can successfully invade hepatocytes but are unable to initiate or complete liver-stage development, leading to early developmental arrest. This characteristic makes SAP1 a primary target for the development of Genetically Attenuated Parasite (GAP) vaccines, which aim to induce sterile immunity by exposing the host to non-pathogenic, arrested parasites. While it is not currently a target for approved small-molecule drugs, its essentiality for establishing infection makes it a high-priority candidate for novel antimalarial strategies focused on preventing the clinical phase of the disease.

Other names

PfSAP1Sporozoite asparagine-rich protein 1P. falciparum SAP1

Not applicable (primarily a target for vaccine-mediated attenuation rather than small molecule inhibition)